Literature DB >> 16734088

Outcome of dogs with diabetic ketoacidosis: 127 dogs (1993-2003).

Daniel Z Hume1, Kenneth J Drobatz, Rebecka S Hess.   

Abstract

The aim of this study was to retrospectively describe the outcome of 127 dogs with naturally occurring diabetic ketoacidosis (DKA) and to examine the association between outcome of canine DKA and clinical and clinicopathologic findings. Eighty-two (65%) dogs were diagnosed with DKA at the time of initial diagnosis of diabetes mellitus (DM). Eighty-seven dogs (69%) had one or more concurrent disorders diagnosed at the time of hospitalization. Commonly identified concurrent conditions included acute pancreatitis (52, 41%), urinary tract infection (21, 20%), and hyperadrenocorticism (19, 15%). Dogs with coexisting hyperadrenocorticism were less likely to be discharged from the hospital (P = .029). Of 121 treated dogs, 89 dogs (70%) survived to be discharged from the hospital, with a median hospitalization of 6 days. Nonsurvivors had lower ionized calcium concentration (P < .001), lower hematocrit (P = .036), lower venous pH (P = .0058), and larger base deficit (P = .0066) than did survivors. Time from admission to initiation of subcutaneous insulin therapy was correlated with lower serum potassium concentration (P = .0056), lower serum phosphorus concentration (P = .0043), abnormally high white blood cell count (P = .0060), large base deficit (P = .0015), and low venous pH (P < .001). Multivariate analysis showed that base deficit was associated with outcome (P = .021). For each unit increase in the base deficit, there was a 9%) greater likelihood of discharge from the hospital. In conclusion, the majority of dogs with DKA were not previously diagnosed with DM. Concurrent conditions and electrolyte abnormalities are common in DKA and are associated with length of hospitalization. Survival was correlated to degree of anemia, hypocalcemia, and acidosis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16734088     DOI: 10.1892/0891-6640(2006)20[547:oodwdk]2.0.co;2

Source DB:  PubMed          Journal:  J Vet Intern Med        ISSN: 0891-6640            Impact factor:   3.333


  22 in total

1.  Diabetic ketoacidosis with concurrent pancreatitis, pancreatic β islet cell tumor, and adrenal disease in an obese ferret (Mustela putorius furo).

Authors:  Kristen A Phair; James W Carpenter; Thomas Schermerhorn; Chanran K Ganta; Brad M DeBey
Journal:  J Am Assoc Lab Anim Sci       Date:  2011-07       Impact factor: 1.232

2.  Upregulation of proinflammatory cytokine production in response to bacterial pathogen-associated molecular patterns in dogs with diabetes mellitus undergoing insulin therapy.

Authors:  Amy E DeClue; Jordan Nickell; Chee-hoon Chang; Allison Honaker
Journal:  J Diabetes Sci Technol       Date:  2012-05-01

3.  Extreme Beta-Cell Deficiency in Pancreata of Dogs with Canine Diabetes.

Authors:  Emily J Shields; Carol J Lam; Aaron R Cox; Matthew M Rankin; Thomas J Van Winkle; Rebecka S Hess; Jake A Kushner
Journal:  PLoS One       Date:  2015-06-09       Impact factor: 3.240

4.  Accuracy of capillary blood 3-β-hydroxybutyrate determination for the detection and treatment of canine diabetic ketoacidosis.

Authors:  Francesca Bresciani; Marco Pietra; Sara Corradini; Massimo Giunti; Federico Fracassi
Journal:  J Vet Sci       Date:  2014-03-21       Impact factor: 1.672

5.  Pancreatic Lipase Immunoreactivity in Serum of Dogs with Diabetic Ketoacidosis.

Authors:  T A Bolton; A Cook; J M Steiner; G T Fosgate
Journal:  J Vet Intern Med       Date:  2016-05-07       Impact factor: 3.333

6.  Comparative Pathogenesis of Autoimmune Diabetes in Humans, NOD Mice, and Canines: Has a Valuable Animal Model of Type 1 Diabetes Been Overlooked?

Authors:  Allison L O'Kell; Clive Wasserfall; Brian Catchpole; Lucy J Davison; Rebecka S Hess; Jake A Kushner; Mark A Atkinson
Journal:  Diabetes       Date:  2017-06       Impact factor: 9.461

7.  Comparison of Survival Times for Dogs with Pituitary-Dependent Hyperadrenocorticism in a Primary-Care Hospital: Treated with Trilostane versus Untreated.

Authors:  N Nagata; K Kojima; M Yuki
Journal:  J Vet Intern Med       Date:  2016-12-01       Impact factor: 3.333

8.  Beta-hydroxybutyrate Concentrations in Dogs with Acute Pancreatitis and Without Diabetes Mellitus.

Authors:  F E Hurrell; K J Drobatz; R S Hess
Journal:  J Vet Intern Med       Date:  2016-04-13       Impact factor: 3.333

Review 9.  What's in a Name? Classification of Diabetes Mellitus in Veterinary Medicine and Why It Matters.

Authors:  C Gilor; S J M Niessen; E Furrow; S P DiBartola
Journal:  J Vet Intern Med       Date:  2016-07       Impact factor: 3.333

10.  Spectrophotometry and Ultracentrifugation for Measurement of Plasma Lipids in Dogs with Diabetes Mellitus.

Authors:  E C Seage; K J Drobatz; R S Hess
Journal:  J Vet Intern Med       Date:  2017-11-29       Impact factor: 3.333

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.